Healthcare is an issue we all care about, and all of us—including those we love—will need medicine one day. AAM encourages voters and patients to advocate at the federal and state level for accessible prescription drugs. Your voice and your stories make a difference to policymakers and regulators.
Although advocacy priorities can change from month to month and year to year, a foundational principle remains: policy that helps foster a sustainable market for the generic and biosimilar industry ensures lower-cost medicines are always available for America’s patients.
